Estrogen

Estrogen

Batur P et al. Menopausal hormone therapy (HT) in patients with breast cancer. Maturitas. 2006 Jan 20;53(2):123-32

Duckles SP et al. Estrogen and Mitochondria: a New Paradigm for Vascular Protection? Molecular Interventions. 6:26-35 (2006)

Fournier A et al. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer. 2005 Apr10;114(3):448-54

Fournier A et al. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Cancer Res Treat. 2008 Jan;107(1):103-11

Grodstein F et al. The Role of Time since Menopause and Age at Hormone Initiation. Women’s Health J Hormone Therapy and Coronary Heart Disease: 2006 Jan/Feb;15

Klaiber EL et al. A critique of the Women’s Health Initiative hormone therapy study. Fertil Steril. 2005 Dec; 84(6):1589-601

Menon DV et al. Effects of transdermal estrogen replacement therapy on cardiovascular risk factors. Treat Endocrinol. 2006;5(1):37-51

Mishra RG et al. Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H295-303

Ouyang P et al. Hormone replacement therapy and the cardiovascular system: lessons learned and unanswered questions. J Am Coll Cardiol. 2006 May 2;47(9):1741-53

Philip KL et al. Greater antiarrhythmic activity of acute 17 beta-estradiol in female than male anaesthetized rats: correlation with Ca(2+) channel blockade. Br J Pharmacol. 2006 Aug 29

Schmidt M et al. Inflammation and sex hormone metabolism. Ann N Y Acad Sci. 2006 Jun;1069:236-46

Schmidt JW et al. Hormone replacement therapy in menopausal women: Past problems and future possibilities. Gynecol Endocrinol. 2006 Oct;22(10):564-77

Tivesten A et al. Circulating Estradiol is an Independent Predictor of Progression of Carotid Artery Intima-Media Thickness in Middle-Aged Men. J Clin Endo & Met. 2006 Nov;91(11):4433-7